Search - tctmd.com

Displaying 661 - 680 of 1334

Sort: Relevancy | Date

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Daily News

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Jason Kahn

May 15, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Industry News

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

May 08, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

Oral Anticoagulation Underused in Japanese A-fib Patients Undergoing PCI

Caitlin E. Cox

April 30, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

Yael L. Maxwell

April 17, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

Advertisement

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Oral Anticoagulation Underused in Japanese A-fib Patients Undergoing PCI

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Poor Adherence to Dabigatran Common, Linked with Worse Clinical Outcomes

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content